Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-052709

Options or other derivatives

  • Director acquired 222,036 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

THURMAN RANDY H · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,000 15,000 D
2019-10-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +207,036 $0.99 $203,993 207,036 D
Loading xslF345X03/doc4.xml…